Breitwieser, Gerda E., and Lucio Gama. Calcium-sensing receptor activation induces intracellular calcium oscillations. Am J Physiol Cell Physiol 280: C1412-C1421, 2001.-Parathyroid hormone secretion is exquisitely sensitive to small changes in serum Ca 2ϩ concentration, and these responses are transduced via the Ca 2ϩ -sensing receptor (CaR). We utilized heterologous expression in HEK-293 cells to determine the effects of small, physiologically relevant perturbations in extracellular Ca 2ϩ on CaR signaling via phosphatidylinositol-phospholipase C, using changes in fura 2 fluorescence to quantify intracellular Ca 2ϩ . Chronic exposure of CaR-transfected cells to Ca 2ϩ in the range from 0.5 to 3 mM modulated the resting intracellular Ca 2ϩ concentration and the subsequent cellular responses to acute extracellular Ca 2ϩ perturbations but had no effect on thapsigargin-sensitive Ca 2ϩ stores. Modest, physiologically relevant increases in extracellular Ca 2ϩ concentration (0.5 mM increments) caused sustained (30-40 min) low-frequency oscillations of intracellular Ca 2ϩ (ϳ45 s peak to peak interval). Oscillations were eliminated by 1 M thapsigargin but were insensitive to protein kinase inhibitors (staurosporine, KN-93, or bisindolylmaleimide I). Staurosporine did increase the fraction of cells oscillating at a given extracellular Ca 2ϩ concentration. Serum Ca 2ϩ concentrations thus chronically regulate cells expressing CaR, and small perturbations in extracellular Ca 2ϩ alter both resting intracellular Ca 2ϩ as well as Ca 2ϩ dynamics. fura 2; intracellular calcium; calcium oscillations; thapsigargin-sensitive calcium stores; HEK-293 cells; protein kinase inhibitors THE CALCIUM-SENSING RECEPTOR (CaR) was hypothesized to exist based on the sensitivity of parathyroid hormone secretion to serum calcium (5, 24) . Expression cloning utilizing RNA isolated from parathyroid cells resulted in identification of the CaR (6), which is activated by extracellular Ca 2ϩ in the physiological range (0.5-5 mM). A unique feature of CaR is the steep cooperativity of Ca 2ϩ -dependent activation, which is observed both in vivo (26) and when CaR is heterologously expressed (6, 15) . In the parathyroid, CaR is chronically exposed to serum Ca 2ϩ concentrations that are within the steeply cooperative range of its doseresponse relation (EC 50 of 2-3 mM, and Hill coefficient n Ϸ 2-3), providing tight control over parathyroid hormone secretion. Although these qualitative details of CaR-mediated modulation of parathyroid hormone secretion are well characterized, the kinetics of singlecell responses to tonic, physiological changes in extracellular Ca 2ϩ have not been studied. CaR couples changes in extracellular Ca 2ϩ to a variety of intracellular responses, including activation of phospholipases, generation of inositol trisphosphate (IP 3 ) and diacylglycerol, increases in intracellular Ca 2ϩ , changes in protein phosphorylation, activation of ion channels, regulation of hormone secretion, and modulation of gene expression (32) . Chronic activation of CaR resulting from constant exposure to serum Ca 2ϩ would necessarily contribute to regulation of cellular functions through many of these pathways. Under conditions of constant agonist exposure, however, many G protein-coupled receptors undergo desensitization and, ultimately, downregulation of receptor and/or signal transduction pathway protein expression (7, 13 oscillations. These results have implications for the mechanism(s) by which CaR activation regulates parathyroid hormone secretion as well as diverse cellular signal transduction pathways in many other cell types.
METHODS
Cell culture and transfection. HEK-293 cells (American Type Culture Collection, Rockville, MD) were grown in high-glucose DMEM (Life Technologies, Grand Island, NY) supplemented with 10% BSA (Sigma, St. Louis, MO), 50 U/ml penicillin, and 50 g/ml streptomycin (37°C, 5% CO 2). Cells were transiently or stably transfected with the human CaR (obtained from Dr. Klaus Seuwen, Novartis Pharma, Basel, Switzerland), which was subcloned into pEGFPN3 (Clontech Laboratories, Palo Alto, CA) as previously described (15) . HEK-293 cells were transfected with 1 g of each CaR construct using Effectene (Quiagen, Valencia, CA) or Novafector (VennNova, Pompano, FL), plated on collagen-coated coverslips, and kept in a 5% CO 2 incubator at 37°C until use (generally 72 h after transfection). HEK-293 cells stably expressing human CaR were produced by linearization of the hCaR-pEGFPN3 plasmid, transfected as described above, and selected with Geneticin (Life Technologies). Colonies were selected after 3 wk, and clones were confirmed by sequencing, CaR activity, and Western blotting with anti-green fluorescent protein (GFP) antibody (Molecular Probes, Eugene, OR).
Single-cell fluorescence measurements of intracellular Ca 2ϩ . Cells were loaded with 0.5 M fura 2-AM (CalbiochemNovabiochem, San Diego, CA) for 30 min at 37°C in a solution containing variable CaCl2 (0.5, 2, or 3 mM), 130 mM NaCl, 5 mM KCl, 1 mM MgSO4, 20 mM HEPES, 0.83 mM Na2HPO4, 0.17 mM NaH2PO4, 25 mM mannose, and 1 mg/ml BSA, pH 7.4. After the loading period, the coverslip was mounted in an imaging chamber (Warner Instrument, Hamden, CT) having both a top and bottom coverslip and washed with a bath solution having a CaCl 2 concentration matched to the loading solution plus 140 mM NaCl, 5 mM KCl, 0.55 mM MgCl2, 10 mM HEPES, pH 7.4. Selected regions of the field were excited at 340/380 nm (emission wavelength 510 nm) at 8-or 10-s intervals (10 frame averaging) on a Universal imaging system (Universal Imaging, West Chester, PA) based on the MetaFluor software package. Background images at the same settings used during a particular experiment were obtained on regions of the coverslip devoid of cells. Calibration of intracellular Ca 2ϩ utilized a series of buffered Ca 2ϩ standards (Molecular Probes), assuming a dissociation constant of 145 nM (determined in vitro at 22°C; Molecular Probes Handbook, 7th edition). All solutions were osmolality matched (290-300 mosM), measured on a Wescor 5500 vapor pressure osmometer (Wescor, Salt Lake City, UT). Variations in extracellular Ca 2ϩ concentration were produced by isosmolar substitution for NaCl. Thapsigargin and the protein kinase inhibitors bisindolylmaleimide I, KN-93, and staurosporine (Calbiochem-Novabiochem) were prepared as stock solutions in DMSO and added to the appropriate extracellular solution. DMSO controls were performed under identical experimental conditions and had no effect on measured parameters. All experiments were performed at room temperature (22-24°C). Multiple cells were analyzed from at least three independent transfections or cell passages (for stably transfected cell lines). Data obtained from stably and transiently transfected HEK-293 cells were comparable, and each result was verified for both conditions. Data were normalized/averaged as described in the text and are presented as means Ϯ SE. Curves were fitted by least-squares minimization using the Marquardt-Levenberg algorithm (NFIT; Island Products, Galveston, TX). Statistical significance was determined by unpaired t-test (SigmaPlot 2000 for Windows, version 6), with significance ascribed at P Ͻ 0.01. . Figure 1A illustrates a typical experiment in which extracellular Ca 2ϩ is progressively increased from a baseline value of 0.5 to 30 mM, and intracellular Ca 2ϩ is monitored with fura 2 fluorescence. Data compiled from 20 cells in this representative experiment were fitted with the Hill equation (Fig. 1B) . Cells were therefore maintained in a fixed concentration of extracellular Ca 2ϩ throughout loading and initiation of the experiment (30-40 min). Intracellular Ca 2ϩ was determined at the start of the experiment (within the first minute of recording). The averaged results of this type of experiment are illustrated in Fig. 2A . Culture, loading, and initiation of the experiment in elevated extracellular Ca 2ϩ (Ͼ0.5 mM) significantly increased both intracellular Ca 2ϩ and the range of intracellular Ca concentrations observed ( Fig. 2A, 2 ). Similar experiments were performed on control HEK-293 cells (Fig.  2B) ; no systematic effects on intracellular Ca 2ϩ were observed, i.e., intracellular Ca 2ϩ concentration after 2 mM preincubation was approximately equal to that after 3 mM preincubation (although both had an intracellular Ca 2ϩ concentration higher than that observed after preincubation in 0.5 mM Ca 2ϩ ). Acute CaR-mediated changes in intracellular Ca 2ϩ were assessed by measuring the response to a decrease in extracellular Ca 2ϩ from 2 to 0. 
RESULTS
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2ϩ content of thapsigargin-sensitive stores. Expression of CaR has a significant effect on resting intracellular Ca 2ϩ concentrations when cells are exposed to extracellular Ca 2ϩ concentrations in the physiological range, i.e., 0.5-3 mM (Fig. 2) . A second compartment of intracellular Ca 2ϩ that might be affected by CaR expression (and chronic activation) is the thapsigargin-sensitive store, which releases Ca 2ϩ on CaR activation (32) . To assess the content of thapsigargin-sensitive stores after exposure of CaR-expressing HEK-293 cells to 0.5, 2, or 3 mM extracellular Ca Close inspection of the traces illustrated in Fig. 3 suggest that, in addition to a significant decrease in the content of thapsigargin-releasable Ca 2ϩ stores, expression of CaR also increases the kinetic complexity of the intracellular Ca 2ϩ transients. In particular, cells expressing CaR are more sensitive to removal of bath Ca 2ϩ , e.g., HEK-293 cells (Fig. 3C ) are relatively insensitive to switching from 3 mM to zero bath Ca 2ϩ , whereas CaR-expressing cells (Fig. 3F) Significance was determined relative to 0.5 mM at P Ͻ 0.01 (*) or 2 mM at P Ͻ 0.01 (**). B: untransfected HEK-293 cells were subjected to the same protocol as in A, with significance determined relative to 0.5 mM at P Ͻ 0.01 (*). C: 20 cells were exposed to 2 mM extracellular Ca 2ϩ , then to 0.5 mM, and then returned to 2 mM. Average intracellular Ca 2ϩ at steady state in each condition was measured. Significance is relative to 2 mM at P Ͻ 0.01 (*). Data are representative of 3 independent experiments. D: protocol similar to that of C performed in untransfected HEK-293 cells.
cells and CaR-expressing cells preincubated in various extracellular Ca 2ϩ concentrations (Fig. 4B ). There were no significant differences in half times for the thapsigargin response when the averages of all cells in each condition were used to determine half times (Ͼ60 cells/condition). . The oscillatory change in intracellular Ca 2ϩ ceased abruptly when extracellular Ca 2ϩ was decreased to 2 mM. At the end of the experiment, the cells were exposed to a concentration of extracellular Ca 2ϩ that maximally activates CaR (20 mM). This concentration of extracellular Ca 2ϩ generated a rapidly activating peak of intracellular Ca 2ϩ (up to 200 nM), which decayed to an elevated plateau for the duration of agonist exposure. This representative experiment illustrates the range of responses to alterations in Fig. 6, A, B , and C, respectively. Inspection of the plots reveals that cells do not oscillate in the extracellular Ca 2ϩ concentration in which they have been loaded with fura 2-AM (although there are differences in resting intracellular Ca 2ϩ concentrations, as documented in Figs. 2 and 3) . Cells loaded in 2 or 3 mM extracellular Ca 2ϩ begin to oscillate after the first 0.5 mM increment in extracellular Ca , and the results are illustrated in Fig. 6D .
Small changes in extracellular Ca
Oscillation frequency is constant. The dependence of the oscillation frequency on extracellular Ca 2ϩ , characterized by the peak to peak duration, was analyzed for the experiments in Fig. 6 , A-C, plotted in Fig. 6E . Regardless of the preconditioning extracellular Ca 2ϩ , the peak to peak intervals of the oscillations elicited over the range of extracellular Ca 2ϩ concentrations from 2.5 to 5 mM were comparable; the average of all conditions was 46.8 s (indicated by the dashed line in Fig. 6E) .
Dependence of oscillations on intracellular Ca 2ϩ
. Oscillations induced by small changes in extracellular Ca 2ϩ were sustained for periods up to 30 min. An example is illustrated in Fig. 7 . In this experiment, the oscillations were initiated by a step change in extracellular Ca 2ϩ from 2 to 3 mM, and intracellular Ca 2ϩ was monitored until oscillations dissipated. The insets in . Despite the cessation of oscillations, the cells exhibited an elevated intracellular Ca 2ϩ in the presence of 3 mM extracellular Ca 2ϩ , which decreased on return to 2 mM Ca 2ϩ , e.g., Fig. 7 . Figure 8A illustrates an experiment designed to determine whether there is a relationship between sustained oscillations and the level of Ca 2ϩ in intracellular stores. In this experiment, cells were exposed twice to 3.5 mM extracellular Ca 2ϩ , from a baseline extracellular Ca 2ϩ of 2 mM. Each time, there was an initial peak of intracellular Ca 2ϩ release, followed by oscillations that were sustained for the duration of the exposure to 3.5 mM extracellular Ca 2ϩ . The peak to peak intervals of the oscillations during the first and second exposures to 3.5 mM Ca 2ϩ were comparable (Fig. 8B) , while the initial peak release of intracellular Ca 2ϩ on agonist addition decreased by 45% and the baseline intracellular Ca 2ϩ in 2 mM extracellular Ca 2ϩ decreased significantly during the experiment (Fig. 8C) . Similar behavior was observed in Ͼ10 independent experiments. These results suggest that neither the ability to support sustained intracellular Ca 2ϩ oscillations nor the oscillation frequency is a simple function of the resting level of intracellular Ca 2ϩ or the degree of loading of intracellular Ca 2ϩ stores as inferred from the initial peak response.
Intracellular stores are, however, intimately involved in maintenance of the intracellular Ca 2ϩ oscillations, as indicated by the experiments in Fig. 9 . Figure 9A illustrates a control experiment in which , and baseline Ca 2ϩ was determined before, between, and after the 2 exposures to 3.5 mM Ca 2ϩ . In both cases, there was a significant decrease in Ca 2ϩ (*P Ͻ 0.01).
oscillations were induced by an increase in extracellular Ca 2ϩ to 3.5 mM from a baseline Ca 2ϩ of 2 mM. Oscillations were sustained until the experiment was ended with exposure of the cells to 10 mM Ca 2ϩ to elicit a maximal CaR-mediated response. The companion experiment, illustrated in Fig. 9B , begins in the same manner, but after 4 min of oscillations in 3.5 mM Ca 2ϩ , 1 M thapsigargin was added to the extracellular solution. There was an immediate increase in intracellular Ca 2ϩ as uptake into the thapsigargin-sensitive stores was blocked, followed by a slow decline in intracellular Ca 2ϩ . Intracellular Ca 2ϩ oscillations ceased abruptly on exposure to thapsigargin, before the peak of the thapsigargin response. Thus intracellular Ca 2ϩ oscillations are obligatorily linked to the integrity of the thapsigargin-sensitive intracellular Ca 2ϩ stores. Small step changes in extracellular Ca 2ϩ after the intracellular stores had been compromised by thapsigargin application did not result in the establishment of intracellular Ca 2ϩ oscillations but, rather, generated a monotonic increase in intracellular Ca 2ϩ consistent with influx of extracellular Ca 2ϩ (data not shown).
Regulation of intracellular Ca
2ϩ oscillations. Intracellular Ca 2ϩ oscillations are observed in many cell types, elicited by a wide variety of G protein-coupled receptors that activate the PI-PLC pathway, ultimately causing release of Ca 2ϩ from internal stores by activating intracellular IP 3 receptors, and often inducing influx of Ca 2ϩ from the extracellular medium (16) . For CaR-activated oscillations, the data in Fig. 9 indicate an integral contribution of Ca 2ϩ cycling into and out of intracellular stores. A second widely observed mechanism regulating G protein-coupled receptor activation is cyclical phosphorylation-dephosphorylation, which has been shown to be responsible for mGluR5-mediated intracellular Ca 2ϩ oscillations in neurons (14, 22) and in heterologous expression systems (19) . The effects of several protein kinase inhibitors were therefore tested for their ability to regulate CaR-mediated Ca 2ϩ oscillations. Figure 10 illustrates the results of typical experiments with staurosporine, a broadspecificity protein kinase inhibitor that was applied at a concentration (100 nM) that should inhibit protein kinases A (IC 50 Ϸ 15 nM), C (IC 50 Ϸ 7 nM), G (IC 50 Ϸ 8.5 nM), myosin light chain kinase (IC 50 Ϸ 1.3 nM), and calmodulin kinase (IC 50 Ϸ 20 nM). In the control experiment, intracellular Ca 2ϩ oscillations were elicited by a step change in extracellular Ca 2ϩ from 2 to 3.5 mM and were sustained until a maximal response was elicited by 10 mM extracellular Ca 2ϩ at the end of the experiment (Fig. 10A) . The companion experiment utilized the same 2.0-3.5 mM step in extracellular Ca 2ϩ to elicit oscillations, and then 100 nM staurosporine was applied during the oscillations (Fig. 10B) . In this and all other experiments of similar protocol, there was no effect on oscillation frequency on addition of staurosporine, although, in some experiments, including that illustrated in Fig. 10B , there was a decrease in the maximum intracellular Ca 2ϩ response during oscillations. To determine whether the lack of effect of staurosporine on oscillation frequency was due to slow diffusion of the blocker into the cells, a second protocol was used to assess the effect(s) of the protein kinase inhibitor (Fig. 10C ): oscillations were elicited by a step from 2 to 3.5 mM Ca 2ϩ , followed by return to 2 mM Ca 2ϩ , application of 100 nM staurosporine for 2 min, and then a second step to 3.5 mM Ca 2ϩ in the continued presence of staurosporine. As with the protocol of Fig. 10B , there was no effect of staurosporine on oscillation frequency despite the 2-min preexposure to the blocker. Experiments similar to that illustrated in Fig.  10B were also performed with 1 M bisindolylmaleimide I and 5 M KN-93, inhibitors of protein kinase C (IC 50 Ϸ 8-200 nM, depending on isoform) and calmodulin kinase II (IC 50 Ϸ 370 nM) , respectively. Although the protein kinase inhibitors did induce a decrease in baseline intracellular Ca 2ϩ and the maximal peak Ca 2ϩ of the oscillations in some experiments, none of the inhibitors blocked the oscillations or affected the peak to peak interval of the oscillations (Fig. 10D) . These results suggest that protein kinases are not required for initiation or maintenance of intracellular Ca 2ϩ oscillations elicited by CaR activation. As a final test for the potential involvement of protein kinases in the establishment or regulation of CaRmediated intracellular Ca 2ϩ oscillations, the ability of staurosporine to alter the threshold for CaR-mediated oscillations was determined. Experiments were performed as in Fig. 6C , with cells exposed to 3 mM extracellular Ca 2ϩ during fura 2-AM loading and experiment initiation, with 100 nM staurosporine present throughout the experiment. The percent of oscillating cells was determined over the range of ex- tracellular Ca 2ϩ from 3 to 5 mM. The results are illustrated in Fig. 10E , with the control data (absence of 100 nM staurosporine) redrawn from Fig. 6D . Staurosporine induced an increase in the number of oscillating cells at every extracellular Ca 2ϩ concentration, although the oscillation frequency was unaffected (data not shown, but see Fig. 10, A-D . In addition, the low level of CaR activation under these conditions may "sensitize" cells expressing CaR to activation of other G protein-coupled receptors that also utilize the PI-PLC pathway for cellular signaling. This sensitizing effect has recently been seen in monocytes coactivated by extracellular Ca 2ϩ and the chemokine MCP-1 (25).
Increasing extracellular Ca 2ϩ by as little as 0.5 mM in the range around the EC 50 for CaR activation generates low-frequency (40-to 50-s peak to peak interval) intracellular Ca 2ϩ oscillations. The oscillation interval is independent of the extracellular Ca 2ϩ concentration, although the number of cells responding to the perturbation of extracellular Ca 2ϩ peaks at ϳ1 mM above the ambient extracellular Ca 2ϩ . Cells expressing CaR acclimate to the ambient concentration of extracellular Ca 2ϩ with a cessation of oscillations after 30-40 min (Fig. 7) . The threshold for initiation of intracellular Ca 2ϩ oscillations is thus reset by the concentration of extracellular Ca 2ϩ to which the cells are chronically exposed. This "resetting" of the threshold for initiation of oscillations is not due to alterations in the Ca 2ϩ content of intracellular stores (Fig. 4) . In parathyroid cells in vivo, increases in extracellular Ca 2ϩ Ͼ1.8 mM induce oscillations with an interval of 42 s (21). Our results suggest that this oscillatory behavior (oscillation interval, threshold) can be conferred on a heterologous cell type by expression of CaR and therefore must be inherent in either CaR or highly conserved elements of the PI-PLC signaling pathway.
Many G protein-coupled receptors that activate the PI-PLC pathway generate intracellular Ca 2ϩ oscillations over a limited agonist concentration range. Oscillation frequencies range from very rapid "pacemaker" activity (1 Hz) that signifies elemental Ca 2ϩ release events (4) to intermediate (3-4 min Ϫ1 ) (2), to slow (Ͻ1 min Ϫ1 ) (12) . Agonist concentration-dependent alterations in oscillation frequency have also been noted (10, 12, 23, 27, 28 Fig. 9A . B: effect of staurosporine on oscillations induced by 3.5 mM Ca 2ϩ . Cells were exposed to 3.5 mM Ca 2ϩ for 4 min to permit determination of oscillation interval, then 100 nM staurosporine was added in the continued presence of 3.5 mM Ca 2ϩ . C: two-pulse protocol, similar to that illustrated in Fig. 8A . Immediately on washout of the first exposure to 3.5 mM, cells were exposed to 100 nM staurosporine, and then, after 4 min, cells were tested with a second exposure to 3.5 mM Ca 2ϩ (in the continued presence of staurosporine). D: summary of protein kinase inhibitor studies on oscillation frequency. Data from 3 independent experiments (Ͼ60 cells) utilizing the protocol illustrated in B were averaged for each inhibitor. Solid bars, no blocker; open bars, protein kinase inhibitor. E: experiments such as those in Fig. 6 , A-C, were performed in the continuous presence of 100 nM staurosporine, and the percent of oscillating cells was determined at each Ca 2ϩ concentration Ͼ3 mM. Plotted are the average percent oscillating cells for 60 cells from 3 independent experiments. The solid line is control data (absence of staurosporine) redrawn from (14, 22) and in vitro (19) and result from the cyclical protein kinase C-mediated phosphorylation and dephosphorylation of the receptor itself, at a threonine residue within the carboxy terminus (19) . Sequence alignment of CaR with mGluR5 suggests that the critical threonine of mGluR5 is present in CaR, although it is not part of a consensus sequence for protein kinase C phosphorylation in CaR (1, 8) . Furthermore, we have generated truncations of the carboxy terminus in which all of the consensus sites for protein kinases A and C phosphorylation were removed (15) . These truncated forms of human CaR were also observed to oscillate (data not shown).
In this report, we have tested the effects of a variety of protein kinase inhibitors, with a particular focus on those that are regulated by Ca 2ϩ . Neither staurosporine, bisindolylmaleimide I, nor KN-93 altered the frequency of oscillations elicited by extracellular Ca 2ϩ . Protein kinase C-mediated phosphorylation of CaR causes a reduction in Ca 2ϩ affinity of the receptor (1, 8, 26) . For the cholecystokinin receptor, a similar protein kinase C-mediated decrease in agonist affinity of the cholecystokinin 8 receptor is responsible for the cessation of intracellular Ca 2ϩ oscillations (31) . It is therefore possible that protein kinase C-mediated phosphorylation of CaR at low agonist concentrations is responsible for the shift in threshold for initiation of oscillations observed in the "Ca 2ϩ pretreatment" protocol, since staurosporine, a broad-specificity protein kinase inhibitor, increased the number of cells oscillating at each extracellular Ca 2ϩ concentration (Fig. 10E ). Further work on protein kinase C-specific site mutants of CaR will be needed to explicitly address this possibility.
Parathyroid hormone secretion is inversely controlled by extracellular Ca 2ϩ , i.e., increases in extracellular Ca 2ϩ result in decreases in parathyroid hormone secretion (32) . Despite intensive efforts, a fundamental question with regard to CaR regulation of parathyroid hormone secretion remains the locus of the inversion signal, given the observation that CaR activation mediates an increase in intracellular Ca 2ϩ . A confocal study that followed subcellular changes in intracellular Ca 2ϩ on a step change in extracellular Ca 2ϩ from 0.5 to 2 mM noted significant time-dependent inhomogeneities in intracellular Ca 2ϩ (9) . In this study, we have shown that global intracellular Ca 2ϩ also exhibits oscillations over this concentration range. It is possible that the global and local oscillatory changes in intracellular Ca 2ϩ contribute to the inversion of the secretory response. At a minimum, any model for CaR-mediated regulation of parathyroid hormone secretion must incorporate intracellular Ca 2ϩ oscillations.
CaR contributes to the regulation of diverse physiological functions, and there may be unique implications of CaR-mediated intracellular Ca 2ϩ oscillations that depend on cell type. It is interesting to note, however, that intracellular Ca 2ϩ oscillations have been recognized recently as an extremely potent and specific means of increasing gene expression (11, 17, 20) . While direct contributions of CaR activation to changes in gene expression have not been explicitly determined in most systems, there is evidence in the Caco-2 intestinal epithelial cell line for rapid, CaR-mediated increases in c-myc expression (18) . In addition, CaR activation potently mediates keratinocyte differentiation (3). Our results suggest that another important locus for CaRmediated signaling that should be explored is the dynamic regulation of gene expression via intracellular Ca 2ϩ oscillations.
